Archive for: November 2008

HealthDay - FRIDAY, Nov. 21 (HealthDay News) -- The cancer-fighting pill Iressa works as well as chemotherapy as a second-line treatment for lung cancer, researchers report.

AP - Some advanced lung cancer patients already treated with chemotherapy might be able to skip some of the bad side effects of another series of chemo by taking a pill instead, a study suggests. An international study showed patients on Iressa, an expensive, newer targeted treatment, survived about as long as those on another course of chemotherapy.

Reuters - The lung cancer pill Iressa has shown surprising results for patients with advanced disease where it has been at least as effective as a standard chemotherapy treatment, researchers reported on Thursday.

HealthDay - SUNDAY, Nov. 16 (HealthDay News) -- Coming on the heels of two studies discounting the usefulness of vitamin B, folic acid, vitamin D and calcium supplements for cancer prevention, U.S. researchers report that vitamins C and E supplements won't help prevent cancer, either.

Reuters - Drugs used to control diabetes may lower the risk of prostate cancer, investigators at the University of Tampere in Finland report.

HealthDay - MONDAY, Nov. 17 (HealthDay News) -- Doctors may someday be able to use five genetic markers to assess whether a man is at high risk to develop prostate cancer, a new study suggests.

Reuters - Middle-aged men who take aspirin or other "nonsteroidal anti-inflammatory drug" (NSAID) have significantly lower levels of a blood protein used to spot prostate cancer than men who don't take these widely used drugs, a study shows.

Reuters - Freezing embryos before undergoing cancer treatment that may cause infertility is as successful for women with cancer as it is for women without cancer, new study findings indicate.

Reuters - A study of Vietnam War era veterans shows that exposure to Agent Orange is associated with more than a two-fold increased risk of prostate cancer, earlier disease onset, and prostate cancer with more aggressive features.